Results 71 to 80 of about 37,316 (268)
Patients with metastatic colorectal cancer who are ineligible for upfront metastasectomy may still become candidates for secondary metastasectomy with curative intent following response to primary chemotherapy. However, most studies dichotomize metastatic colorectal cancer into resectable and unresectable disease.
Julian W. Holch +18 more
wiley +1 more source
In advanced non-squamous non-small-cell lung cancer (NSCLC), routine testing with next-generation sequencing (NGS) is recommended to identify actionable genomic alterations (AGAs).
Shelley Kuang +15 more
doaj +1 more source
Background: Encountering more than one malignancy in a cancer patient is no longer uncommon; this increasing incidence is mostly attributable to the improvements in life expectancy, awareness, and diagnostic facilities.
Niharika Bisht +10 more
doaj +1 more source
Synchronous/Metachronous Multiple Primary Malignancies: Review of Associated Risk Factors
The incidence of secondary primary malignancy (SPM) has been reported to range from 1.33% to 5.8%, according to the location of the primary cancer and the follow-up duration. The highest occurrence rate of SPM, of 36.6% within 6 months, has been reported
Szu-Ying Pan +2 more
doaj +1 more source
Microtubule sliding in swimming sperm flagella: direct and indirect measurements on sea urchin and tunicate spermatozoa [PDF]
Direct measurements of microtubule sliding in the flagella of actively swimming, demembranated, spermatozoa have been made using submicron diameter gold beads as markers on the exposed outer doublet microtubules.
Brokaw, Charles J.
core
Estudio de las lesiones neoplásicas metacrónicas en el carcinoma colorrectal [PDF]
Fundamento. Analizar la frecuencia y las características de las lesiones neoplásicas metacrónicas, carcinomas y adenomas, tras la resección de un cáncer colo-rectal (CCR). Pacientes y métodos.
Borda-Celaya, F. (F.) +5 more
core +1 more source
ABSTRACT Background The peritoneum is the third most prevalent location for metastases of colorectal cancer. In patients with resectable disease, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is the preferred treatment in the Netherlands, achieving median overall survival (OS) of 36–42 months. However, during
Teun van den Heuvel +6 more
wiley +1 more source
Illuminating Bilateral Breast Cancer: A Multicenter Experience and Clinical Observations
Background and Objectives: Although breast cancer is the most common type of cancer among women, bilateral breast cancer (BBC) remains exceedingly rare. BBC can present as either synchronous (SBBC) or metachronous (MBBC) disease.
Berkan Karabuğa +11 more
doaj +1 more source
CLINICAL-STATISTICAL STUDY OF MULTIPLE SYNCHRONOUS AND METACRONE TUMORS [PDF]
Multiple malignant tumors, synchronous, metachronous, represent a subject currently under development. Risk assessment, standardization of screening and and to map the sequences of the occurrence and localization represents current issues.
Nicoleta Aurelia Sanda +5 more
doaj +1 more source
ABSTRACT Background and Objectives This study aimed to evaluate the ability of perioperative inflammatory markers to discriminate postoperative complications within 6 months in patients with ovarian cancer–related peritoneal metastasis undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Donmez Mustafa +6 more
wiley +1 more source

